Cadrenal Therapeutics Files 2024 Annual Report
Ticker: CVKD · Form: 10-K · Filed: Mar 13, 2025 · CIK: 1937993
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
CADRN filed its 2024 10-K. All systems go for pharma prep biz.
AI Summary
Cadrenal Therapeutics, Inc. filed its annual report for the fiscal year ended December 31, 2024. The company, incorporated in Delaware and headquartered in Ponte Vedra, Florida, operates in the pharmaceutical preparations sector. This 10-K filing provides a comprehensive overview of its business, financial condition, and results of operations for the past fiscal year.
Why It Matters
This filing provides investors and stakeholders with crucial information about Cadrenal Therapeutics' financial health and operational performance for the 2024 fiscal year, impacting investment decisions.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Cadrenal Therapeutics faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024 — Fiscal Year End (Reporting period for the 10-K)
- 2025-03-13 — Filing Date (Date the 10-K was submitted to the SEC)
Key Players & Entities
- Cadrenal Therapeutics, Inc. (company) — Registrant
- 2024-12-31 (date) — Fiscal year end
- 2025-03-13 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- Ponte Vedra, Florida (location) — Principal executive offices
- 001-41596 (identifier) — Commission file number
FAQ
What is the primary business of Cadrenal Therapeutics, Inc.?
Cadrenal Therapeutics, Inc. operates in the Pharmaceutical Preparations sector, as indicated by its Standard Industrial Classification code [2834].
When did Cadrenal Therapeutics, Inc. file its 2024 annual report?
Cadrenal Therapeutics, Inc. filed its 10-K for the fiscal year ended December 31, 2024, on March 13, 2025.
Where are Cadrenal Therapeutics, Inc.'s principal executive offices located?
The principal executive offices of Cadrenal Therapeutics, Inc. are located at 822 A1A North, Suite 306, Ponte Vedra, Florida 32082.
What is the commission file number for Cadrenal Therapeutics, Inc.?
The commission file number for Cadrenal Therapeutics, Inc. is 001-41596.
In which state was Cadrenal Therapeutics, Inc. incorporated?
Cadrenal Therapeutics, Inc. was incorporated in Delaware.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 13, 2025 regarding Cadrenal Therapeutics, Inc. (CVKD).